-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MopJFa3TVPbVKOfI7EUExwtA89m84zTtXOvrxhgBom51N4uXo1ztQ4MnqTo3NbeR EnlpgKy69qOvJQNsVpmTTw== 0001144204-07-005917.txt : 20070208 0001144204-07-005917.hdr.sgml : 20070208 20070208162010 ACCESSION NUMBER: 0001144204-07-005917 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 DATE AS OF CHANGE: 20070208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43074 FILM NUMBER: 07592834 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SELTZER DAVID S CENTRAL INDEX KEY: 0001054694 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: C/O TASHLIK KREUTZER & GOLDWYN PC STREET 2: 833 NORTHERN BLVD CITY: GREAT NECK STATE: NY ZIP: 11021 SC 13G/A 1 v064652_sc13g-a.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 9)*

HI-TECH PHARMACAL CO., INC.
(Name of Issuer)

COMMON STOCK
(Title of Class of Securities)

42840B101
(CUSIP Number)

December 31, 2006
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

9 Rule 13d-1(b)
9 Rule 13d-1(c)
: Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

CUSIP NO. 42840B101
13G
Page 2 of 7 Pages
 
 
   
1.
Name of Reporting Persons: David Seltzer
I.R.S. Identification Nos. of above persons (entities only):
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)  Not applicable
 
3.
SEC Use Only
 
4.
Citizenship or Place of Organization: United States
 
 
NUMBER OF SHARES
 
BENEFICIALLY
 
OWNED BY EACH
 
REPORTING PERSON
 
WITH
 
5.
Sole Voting Power
1,787,708
6.
Shared Voting Power
344,028 (1)
7.
Sole Dispositive Power
1,787,708
8.
Shared Dispositive Power
344,028 (1)
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
2,131,736
 
10.
Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions)                            o
 
11.
Percent of Class Represented by Amount in Row (9)
17.1%
 
12.
Type of Reporting Person (See Instructions) IN
 
(1) Amount includes 138,292 shares held in trust for the benefit of two of Mr. David Seltzer’s children, which Mr. David Seltzer has shared power to vote and dispose together with Mr. Reuben Seltzer. These shares are also reported on Mr. Reuben Seltzer’s Schedule 13G. Mr. David Seltzer disclaims beneficial ownership of such shares.
 
 

CUSIP NO. 42840B101
13G
Page 3 of 7 Pages
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
(Amendment No. 9)

Under the Securities Exchange Act of 1934

HI-TECH PHARMACAL CO., INC.
(Name of Issuer)

Item 1(a)

Name of Issuer: Hi-Tech Pharmacal Co., Inc.

Item 1(b)

Address of Issuer=s Principal Executive Offices: 369 Bayview Avenue, Amityville, New York 11701

Item 2(a)

Name of Person Filing: David Seltzer

Item 2(b)

Address of Principal Business Office or, if none, Residence: 369 Bayview Avenue, Amityville, New York 11701

Item 2(c)

Citizenship: United States

Item 2(d)

Title of Class of Securities: Common Stock

Item 2(e)

CUSIP Number: 42840B101
 
 

CUSIP NO. 42840B101
13G
Page 4 of 7 Pages

Item 3

If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a:

(a)  o Broker or dealer registered under Section 15 of the Act
(15 U.S.C. 78o).

(b)      o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)  o Insurance Company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).

(d)      o Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)      o An investment adviser in accordance with §240.13d-1(b)(1) (ii)(E).

(f)       o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

(g)      o A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G).

(h)      o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

(i)   o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

(j)         oGroup, in accordance with §240.13d-1(b)(1)(ii)(J).

Not applicable

Item 4

Ownership:

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)   Amount Beneficially Owned:
2,131,736
………………………………………………………………………………

 
CUSIP NO. 42840B101
13G
Page 5 of 7 Pages
 
(b)   Percent of Class:
17.1%
………………………………………………………………………………

(c)   Number of shares as to which the person has:

(i)
    
Sole power to vote or to direct the vote
   
1,787,708
  
(ii)
    
Shared power to vote or to direct the vote
   
344,028
 (1)
(iii)
    
Sole power to dispose or to direct the disposition of
   
1,787,708
  
(iv)
    
Shared power to dispose or to direct the disposition of
   
344,028
 (1)
 
(1)  Amount includes 138,292 shares held in trust for the benefit of two of Mr. David Seltzer’s children, which Mr. David Seltzer has shared power to vote and dispose together with Mr. Reuben Seltzer. These shares are also reported on Mr. Reuben Seltzer’s Schedule 13G. Mr. David Seltzer disclaims beneficial ownership of such shares.
 
Item 5

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
Item 6

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable
 
 

CUSIP NO. 42840B101
13G
Page 6 of 7 Pages
 
Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable

Item 8

Identification and Classification of Members of the Group.

Not applicable

Item 9

Notice of Dissolution of Group.

Not applicable

Item 10

Certification.

Not applicable


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
Dated: February 6, 2007
 
 		  
 		  
 
/s/ David Seltzer
 
David Seltzer


 
 -----END PRIVACY-ENHANCED MESSAGE-----